CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Statistics

Total Valuation

CRSP has a market cap or net worth of $3.13 billion. The enterprise value is $1.50 billion.

Market Cap	3.13B
Enterprise Value	1.50B

Important Dates

The last earnings date was Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CRSP has 86.36 million shares outstanding. The number of shares has increased by 6.74% in one year.

Current Share Class	86.36M
Shares Outstanding	86.36M
Shares Change (YoY)	+6.74%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	0.48%
Owned by Institutions (%)	72.76%
Float	85.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	82.26
Forward PS	39.29
PB Ratio	1.71
P/TBV Ratio	1.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	39.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.64, with a Debt / Equity ratio of 0.12.

Current Ratio	15.64
Quick Ratio	15.53
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -19.71% and return on invested capital (ROIC) is -13.58%.

Return on Equity (ROE)	-19.71%
Return on Assets (ROA)	-12.88%
Return on Invested Capital (ROIC)	-13.58%
Return on Capital Employed (ROCE)	-23.18%
Revenue Per Employee	$95,865
Profits Per Employee	-$981,316
Employee Count	393
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, CRSP has paid $3.97 million in taxes.

Income Tax	3.97M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.61% in the last 52 weeks. The beta is 1.87, so CRSP's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	-32.61%
50-Day Moving Average	37.09
200-Day Moving Average	43.59
Relative Strength Index (RSI)	46.13
Average Volume (20 Days)	2,062,305

Short Selling Information

The latest short interest is 21.07 million, so 24.39% of the outstanding shares have been sold short.

Short Interest	21.07M
Short Previous Month	21.32M
Short % of Shares Out	24.39%
Short % of Float	24.51%
Short Ratio (days to cover)	11.10

Income Statement

In the last 12 months, CRSP had revenue of $37.68 million and -$385.66 million in losses. Loss per share was -$4.52.

Revenue	37.68M
Gross Profit	-400.08M
Operating Income	-474.40M
Pretax Income	-263.15M
Net Income	-385.66M
EBITDA	-455.24M
EBIT	-474.40M
Loss Per Share	-$4.52

Balance Sheet

The company has $1.86 billion in cash and $219.36 million in debt, giving a net cash position of $1.64 billion or $18.94 per share.

Cash & Cash Equivalents	1.86B
Total Debt	219.36M
Net Cash	1.64B
Net Cash Per Share	$18.94
Equity (Book Value)	1.83B
Book Value Per Share	21.18
Working Capital	1.75B

Cash Flow

In the last 12 months, operating cash flow was -$306.47 million and capital expenditures -$1.39 million, giving a free cash flow of -$307.86 million.

Operating Cash Flow	-306.47M
Capital Expenditures	-1.39M
Free Cash Flow	-307.86M
FCF Per Share	-$3.56

Margins

Gross Margin	n/a
Operating Margin	-1,259.20%
Pretax Margin	-1,013.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.74%
Shareholder Yield	-6.74%
Earnings Yield	-12.31%
FCF Yield	-9.82%

Analyst Forecast

The average price target for CRSP is $73.07, which is 101.35% higher than the current price. The consensus rating is "Buy".

Price Target	$73.07
Price Target Difference	101.35%
Analyst Consensus	Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	130.16%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRSP has an Altman Z-Score of 6.88 and a Piotroski F-Score of 1.

Altman Z-Score	6.88
Piotroski F-Score	1